RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

NCT00808067 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5897

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: dabigatran dose 1
DRUG: dabigatran dose 2

Sponsor

Boehringer Ingelheim